Mechanism and effects of extramedullary hematopoiesis on anti-tumor immunity

Cancer immunotherapy is a preferred strategy for boosting anti-tumor immunity to eliminate malignant cells and is considered a major breakthrough in the field of cancer treatment; however, immunosuppressive cells in the tumor microenvironment (TME) pose a major obstacle to the efficacy of